Page 15 of articles about vaccine

Effect of the viraemia due to the porcine circovirus type 2 (PCV2) on production parameters

The most effective way of avoiding the production losses associated with the PCV2 consists in avoiding the appearance of the viraemia by inducing a passive or an active immunity that minimizes the circulation of the virus in the farm.

Home

Abstract

Oral immunization of weaned piglets with tobacco seeds expressing antigenic proteins of VTEC

Oral administration of recombinant tobacco seeds expressing antigenic proteins against VTEC strains can induce an increase of mucosal antibodies.

Home

Abstract

Regional PRRS control with an autogenous vaccination strategy

Regional vaccination with an autogenous killed vaccine did not effectively reduce the number of PRRSV related crises in the vaccinated farms.

Home

Abstract

Dynamics of influenza transmission in vaccinated and non-vaccinated pig populations

The objective of this study was to determine transmission parameters for an H1N1 influenza virus in vaccinated and non-vaccinated populations of pigs and assess the effect of vaccination on influenza transmission.

Home

Abstract

Estimation of time-dependent infectiousness of pigs infected by the PRRSV

The evolution of infectiousness was mainly correlated with the course of viral genome load in blood.

Home

Abstract

The impact of MDI on influenza virus transmission in neonatal pig populations

This study indicates that vaccine induced maternal immunity may be able to reduce influenza virus transmission in population settings; however, the impact will depend on the priming antigen.

Home

Press releases

Storage and handling - Key to effective vaccination program

A vaccine program can help prevent many potential problems for producers. However, if vaccines aren't stored and handled correctly, the program can be ineffective.

Home

Press releases

Virbac enters in a new technology alliance in food-producing animals vaccines

Virbac has entered into a new strategic alliance in food-producing animals vaccines, by setting up a joint-venture with the Taiwanese company Schweitzer Biotech Company (SBC).

Home

Abstract

Sensitivity of oral fluids for detecting influenza A virus in populations of vaccinated and non-vaccinated pigs

This study evaluates the sensitivity of PCR on oral fluids in detecting influenza virus in vaccinated and non-vaccinated pigs.

Home

Press releases

Controlling disease in young pigs

Mycoplasmal pneumonia and porcine circovirus are two of the costliest diseases affecting pork producers. Helping provide protection before disease exposure is critical to the success of any vaccination program.

Home

News

Galvmed publishes database with vaccine information

The NGO Galvmed has published an online database with free access to information on all livestock vaccines, throughout the world.

Home

Press releases

Merck Animal Health announces European Union approval for PORCILIS M Hyo ID ONCE swine vaccine

Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announced that it has received marketing authorization in the European Union for PORCILIS® M Hyo ID ONCE, the first single-shot vaccine against Mycoplasma hyopneumoniae (M Hyo) infection in pigs for intradermal administration.

Home

Abstract

Effect of porcine circovirus type 2 vaccine on postweaning performance and carcass composition

PCV2 vaccination has a large impact on growth rate and on the proportion of pigs going to primary markets, but not on carcass fat depth, loin depth, or percent lean, measurements that are used to determine market value.

Home

News

FMD situation in Paraguay

There are currently 25 teams in the zone around the outbreak and in the surveillance zone and 13,333 blood samples.

Home

Abstract

Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunization

Experimental immunisation of pigs with the non-virulent OURT88/3 genotype I isolate from Portugal followed by the closely related virulent OURT88/1 genotype I isolate could confer protection against challenge with virulent isolates from Africa.

Home

Press releases

Inovio Pharmaceuticals enters collaboration with U.S. Dept. of Homeland Security to assess foot & mouth disease synthetic vaccines' potential to help ensure Nation's food supply safety

Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Department of Homeland Security (DHS) Science and Technology Directorate Plum Island Animal Disease Center. This collaboration will evaluate the efficacy of Inovio's SynCon® vaccines for foot & mouth disease (FMD) in important animal models including cattle, sheep, and pigs.